Взаємозв'язок варіабельності серцевого ритму з добовим профілем артеріального тиску у хворих на артеріальну гіпертензію
OI Hryniv, LV Glushko - Клінічна та експериментальна патологія, 2017 - cep.bsmu.edu.ua
ВЗАЄМОЗВ'ЯЗОК ВАРІАБЕЛЬНОСТІ СЕРЦЕВОГО РИТМУ З ДОБОВИМ ПРОФІЛЕМ АРТЕ
Page 1 30 Клінічна та експериментальна патологія. 2017. Т.16, №4 (62) ISSN 1727-4338 …
Page 1 30 Клінічна та експериментальна патологія. 2017. Т.16, №4 (62) ISSN 1727-4338 …
[HTML][HTML] Anxiety-related blood pressure variability in patients with atrial fibrillation after cardioembolic stroke
IA Zolotovskaya, IL Davydkin… - Terapevticheskii …, 2017 - edgccjournal.org
Aim. To investigate whether of anxiety-related blood pressure (BP) variability can be
corrected in patients with atrial fibrillation (AF) who have experienced cardioembolic stroke …
corrected in patients with atrial fibrillation (AF) who have experienced cardioembolic stroke …
High blood pressure variability predicts 30-day mortality but not 1-year mortality in hospitalized elderly patients
A Weiss, Y Rudman, Y Beloosesky, A Akirov… - Blood …, 2017 - Taylor & Francis
Background: The association of blood pressure (BP) variability (BPV) in hospitalized
patients, which represents day-to-day variability, with mortality has been extensively …
patients, which represents day-to-day variability, with mortality has been extensively …
[HTML][HTML] Amelioration of arterial pressure lability: an unmissable target for diabetes management
A Tanaka, K Node - Hypertension Research, 2017 - nature.com
Impaired glycemic metabolism and hyper-glycemia play major roles in diabetes
pathophysiology. However, medical interventions in only glycemic changes do not fully …
pathophysiology. However, medical interventions in only glycemic changes do not fully …
Improving cardiovascular risk prediction through more accurate and alternative methods of blood pressure measurement
S Stevens - 2017 - ora.ox.ac.uk
Background Cardiovascular risk scores are used to estimate absolute risk of disease and
identify patients who will benefit most from treatments to lower risk. As a key risk factor for …
identify patients who will benefit most from treatments to lower risk. As a key risk factor for …
Enabling stroke and blood pressure research in UK Biobank
RM Woodfield - 2017 - era.ed.ac.uk
Background Blood pressure is one of the most important modifiable risk factors for stroke.
Although the influence of an individual's average blood pressure (BP) on their overall stroke …
Although the influence of an individual's average blood pressure (BP) on their overall stroke …
[HTML][HTML] Efeitos e Mecanismos da Denervação Simpática Renal por Radiofrequência na Anti-Hipertensão em Cães
W Chen, X Tang, X Yang, C Weng, K Yang… - Arquivos Brasileiros …, 2017 - SciELO Brasil
Fundamentos: A denervação simpática renal por radiofrequência (DSR) mostra redução
eficaz da pressão arterial (PA) de pacientes hipertensos, ainda que os mecanismos …
eficaz da pressão arterial (PA) de pacientes hipertensos, ainda que os mecanismos …
Blood pressure variability: measurement and clinical implications
P Veloudi - 2017 - figshare.utas.edu.au
High blood pressure (BP), measured conventionally using clinic, ambulatory or home BP
monitoring, is associated with target organ damage; however, the exact underlying …
monitoring, is associated with target organ damage; however, the exact underlying …
Visit-to-visit blood pressure variability: an epiphenomenon or a risk for the progression of carotid artery remodelling: reply
JS Kim, S Park, P Yan, BW Jeffers… - European Heart …, 2017 - academic.oup.com
Pharmacotherapy. 1 Nagai et al. 2 had previously reported that in a cohort 201 high-risk
elderly patients, delta of systolic blood pressure (SBP) was associated with maximum intima …
elderly patients, delta of systolic blood pressure (SBP) was associated with maximum intima …
[PDF][PDF] Cardiovascular Prevention
G Mancia, H Schumacher, M Böhm, J Redon… - …, 2017 - researchgate.net
In 28 790 patients recruited for the ONTARGET (Ongoing Treatment Alone and in
Combination With Ramipril Global End Point Trials) and TRANSCEND (Telmisartan …
Combination With Ramipril Global End Point Trials) and TRANSCEND (Telmisartan …